-
1
-
-
0022553499
-
Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynecological surgery
-
Madej T, Simpson K. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynecological surgery. Br J Anaesth 1986; 58:879-83.
-
(1986)
Br J Anaesth
, vol.58
, pp. 879-883
-
-
Madej, T.1
Simpson, K.2
-
2
-
-
0026748304
-
Postoperative nausea and vomiting: Its etiology, treatment, and prevention
-
Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;77: 162-84.
-
(1992)
Anesthesiology
, vol.77
, pp. 162-184
-
-
Watcha, M.F.1
White, P.F.2
-
3
-
-
0028273482
-
Reduction of postoperative nausea and vomiting with granisetron
-
Fujii Y, Tanaka H, Toyooka H. Reduction of postoperative nausea and vomiting with granisetron. Can J Anaesth 1994;41: 291-4.
-
(1994)
Can J Anaesth
, vol.41
, pp. 291-294
-
-
Fujii, Y.1
Tanaka, H.2
Toyooka, H.3
-
4
-
-
0028841665
-
Prevention of postoperative nausea and vomiting with granisetron: A randomized, double-blind comparison with droperidol
-
Fujii Y, Tanaka H, Toyooka H. Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidol. Can J Anaesth 1995;42:852-6.
-
(1995)
Can J Anaesth
, vol.42
, pp. 852-856
-
-
Fujii, Y.1
Tanaka, H.2
Toyooka, H.3
-
5
-
-
0001601748
-
Ramosetron hydrochloride: Affinity for cloned human 5-HT3 receptor and 5-HT3 receptor antagonistic and antiemetic effect in the ferret
-
Fujihara A, Akuzawa S, Miyata K, Miyake A. Ramosetron hydrochloride: affinity for cloned human 5-HT3 receptor and 5-HT3 receptor antagonistic and antiemetic effect in the ferret. Lab Clin 1996;30:1965-72.
-
(1996)
Lab Clin
, vol.30
, pp. 1965-1972
-
-
Fujihara, A.1
Akuzawa, S.2
Miyata, K.3
Miyake, A.4
-
6
-
-
0024208045
-
The antiemetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694
-
Bermudez J, Boyle EA, Minter WD, Sanger GJ. The antiemetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer 1988;58:644-50.
-
(1988)
Br J Cancer
, vol.58
, pp. 644-650
-
-
Bermudez, J.1
Boyle, E.A.2
Minter, W.D.3
Sanger, G.J.4
-
7
-
-
0024360904
-
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: Correlation of anti-emetic response
-
Carmichael J, Cantwell BMJ, Edwards CM, et al. A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation of anti-emetic response. Cancer Chemother Pharmacol 1989;24:45-9.
-
(1989)
Cancer Chemother Pharmacol
, vol.24
, pp. 45-49
-
-
Carmichael, J.1
Cantwell, B.M.J.2
Edwards, C.M.3
-
8
-
-
0027312776
-
Mechanism of cisplatin-and m-chlorophenylbiguanide-induced emesis in ferret
-
Kamato T, Ito H, Nagakura Y, et al. Mechanism of cisplatin-and m-chlorophenylbiguanide-induced emesis in ferret. Eur J Pharmacol 1993;238:369-76.
-
(1993)
Eur J Pharmacol
, vol.238
, pp. 369-376
-
-
Kamato, T.1
Ito, H.2
Nagakura, Y.3
-
9
-
-
0000024585
-
Clinical evaluation of ramosetron against the nausea and vomiting induced by anticancer drugs
-
Noda K, Ikeda M, Yoshida O, et al. Clinical evaluation of ramosetron against the nausea and vomiting induced by anticancer drugs. Jpn J Clin Exp Med 1994;71:2765-76.
-
(1994)
Jpn J Clin Exp Med
, vol.71
, pp. 2765-2776
-
-
Noda, K.1
Ikeda, M.2
Yoshida, O.3
-
10
-
-
0002608091
-
Clinical evaluation of granisetron against nausea and vomiting induced anticancer drugs: Optimal dose-finding study
-
Furue H, Oota K, Taguchi T, Niitani H. Clinical evaluation of granisetron against nausea and vomiting induced anticancer drugs: optimal dose-finding study. J Clin Ther Med 1990;6:49-61.
-
(1990)
J Clin Ther Med
, vol.6
, pp. 49-61
-
-
Furue, H.1
Oota, K.2
Taguchi, T.3
Niitani, H.4
-
11
-
-
0027978317
-
Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting
-
Fujii Y, Tanaka H, Toyooka H. Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting. Can J Anaesth 1994;41:794-7.
-
(1994)
Can J Anaesth
, vol.41
, pp. 794-797
-
-
Fujii, Y.1
Tanaka, H.2
Toyooka, H.3
-
12
-
-
0027970646
-
Clinical evaluation and pharmacokinetics of ramosetron against the nausea and vomiting induced by anticancer drugs
-
Kawabata Y, Sakiyama H, Muto S, et al. Clinical evaluation and pharmacokinetics of ramosetron against the nausea and vomiting induced by anticancer drugs. Nishinihon J Urol 1994;56:1445-56.
-
(1994)
Nishinihon J Urol
, vol.56
, pp. 1445-1456
-
-
Kawabata, Y.1
Sakiyama, H.2
Muto, S.3
-
13
-
-
0002306846
-
Phase I study of granisetron: Pharmacokinetics of granisetron following single and repeat intravenous drips infusion in Japanese healthy volunteers
-
Kumakura H, Koyanagi J, Nishioka Y, et al. Phase I study of granisetron: pharmacokinetics of granisetron following single and repeat intravenous drips infusion in Japanese healthy volunteers. J Clin Ther Med 1990;5:25-34.
-
(1990)
J Clin Ther Med
, vol.5
, pp. 25-34
-
-
Kumakura, H.1
Koyanagi, J.2
Nishioka, Y.3
-
14
-
-
0001601748
-
Ramosetron hydrochloride: Affinity for cloned human 5-HT3 receptor and 5-HT3 receptor antagonistic and antiemetic effect in the ferret
-
Fujihara A, Akuzawa S, Miyata K, Miyake T. Ramosetron hydrochloride: affinity for cloned human 5-HT3 receptor and 5-HT3 receptor antagonistic and antiemetic effect in the ferret. Lab Clin 1996;30:1955-64.
-
(1996)
Lab Clin
, vol.30
, pp. 1955-1964
-
-
Fujihara, A.1
Akuzawa, S.2
Miyata, K.3
Miyake, T.4
-
15
-
-
0029126773
-
Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: A review of published trials
-
Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ 1995;311:844-6.
-
(1995)
BMJ
, vol.311
, pp. 844-846
-
-
Aspinall, R.L.1
Goodman, N.W.2
-
16
-
-
0027964936
-
Granisetron: An update of its therapeutic use in nausea and vomiting induced by antineoplasmic therapy
-
Yarker YE, McTavish D. Granisetron: an update of its therapeutic use in nausea and vomiting induced by antineoplasmic therapy. Drugs 1994;48:761-93.
-
(1994)
Drugs
, vol.48
, pp. 761-793
-
-
Yarker, Y.E.1
McTavish, D.2
-
17
-
-
0027404028
-
Are new drugs cost-effective for patients undergoing ambulatory surgery?
-
White PF, Watcha MF. Are new drugs cost-effective for patients undergoing ambulatory surgery? Anesthesiology 1993;78:2-5.
-
(1993)
Anesthesiology
, vol.78
, pp. 2-5
-
-
White, P.F.1
Watcha, M.F.2
-
18
-
-
0028922078
-
Are antiemetics cost-effective for children?
-
Lerman J. Are antiemetics cost-effective for children? Can J Anaesth 1995;42:263-6.
-
(1995)
Can J Anaesth
, vol.42
, pp. 263-266
-
-
Lerman, J.1
|